GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medistim ASA (OSTO:MEDIO) » Definitions » Change In Receivables

Medistim ASA (OSTO:MEDIO) Change In Receivables : kr0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Medistim ASA Change In Receivables?

Medistim ASA's change in receivables for the quarter that ended in Mar. 2024 was kr0.0 Mil. It means Medistim ASA's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Medistim ASA's change in receivables for the fiscal year that ended in Dec. 2023 was kr27.4 Mil. It means Medistim ASA's Accounts Receivable declined by kr27.4 Mil from Dec. 2022 to Dec. 2023 .

Medistim ASA's Accounts Receivable for the quarter that ended in Mar. 2024 was kr68.1 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Medistim ASA's Days Sales Outstanding for the three months ended in Mar. 2024 was 46.44.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Medistim ASA's liquidation value for the three months ended in Mar. 2024 was kr201.6 Mil.


Medistim ASA Change In Receivables Historical Data

The historical data trend for Medistim ASA's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medistim ASA Change In Receivables Chart

Medistim ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.62 4.70 -11.15 -33.02 27.35

Medistim ASA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Medistim ASA Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medistim ASA  (OSTO:MEDIO) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Medistim ASA's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=68.084/133.788*91
=46.44

2. In Ben Graham's calculation of liquidation value, Medistim ASA's accounts receivable are only considered to be worth 75% of book value:

Medistim ASA's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=170.264-98.419+0.75 * 68.084+0.5 * 157.373
=201.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medistim ASA Change In Receivables Related Terms

Thank you for viewing the detailed overview of Medistim ASA's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Medistim ASA (OSTO:MEDIO) Business Description

Traded in Other Exchanges
Address
Okernveien 94, Oslo, NOR, 0579
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing and sales of medical equipment through its own business or through participation in other companies, as well related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, Asia and the Rest of the World. The firm's activity is split into three strategic operating units, Lease of equipment; Lease of equipment and Distribution and sales of third-party products.

Medistim ASA (OSTO:MEDIO) Headlines

No Headlines